TC BIOPHARM HOLDINGS PLC's ticker is and the CUSIP is 87807D111. A total of 8 filers reported holding TC BIOPHARM HOLDINGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,176 | -48.8% | 235,294 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $10,118 | -57.0% | 235,294 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $23,506 | +11.7% | 235,294 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $21,047 | -27.4% | 235,294 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $29,000 | -48.2% | 235,294 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $56,000 | -52.1% | 235,294 | 0.0% | 0.00% | -40.0% |
| Q1 2022 | $117,000 | – | 235,294 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 2,823,528 | $1,384,000 | 6.50% |
| Altium Capital Management LP | 941,176 | $461,000 | 0.15% |
| ARMISTICE CAPITAL, LLC | 1,882,352 | $922,000 | 0.02% |
| Kepos Capital LP | 470,588 | $231,000 | 0.02% |
| Nantahala Capital Management | 235,294 | $117,000 | 0.01% |
| Virtu Financial LLC | 15,775 | $8,000 | 0.00% |
| Warberg Asset Management LLC | 176,534 | $88,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |